恆指跌幅曾擴至逾900點 港交所/舜宇/美團/銀娛/藥明生物挫逾4%-7%
美國最新就業數據及耐用品訂單遠勝預期，末季GDP略上修續增4.1%，但全年確認萎縮3.5%為74年來最傷，成屋銷售指數按月意外轉降2.8%，加上美債孳息率繼續上升，其中十年期債息去年中以來首次觸及1.6%，重磅科網股仍有沽壓及藍籌股投資者趁高獲利，美股昨晚在各類主要行業無一倖免下全面急挫1.8%-3.5%，納指最傷，道指及標普由曾吐2.1%及2.8%，收窄至僅吐近1.8%及2.5%。亞太區主要股市今早全面下挫，澳洲、台灣、日本及南韓股市急吐2%-2.9%，其中日經曾急吐近950點，半日收挫722點或2.4%；但泰國及假後復市菲股逆市微升。
本港1月出口額及進口額按年升幅進一步擴至44%(前值升11.7%)及37.7%(前值升14.1%)，遠勝市場預期分別升30.5%及28.8%，且分別升三個月及五個月。期內，有形貿易逆差按月再度收窄至252億元，低於去年12月逆差457億元及市場預期逆差445億元。不過，恆指繼昨天由最多急彈734點或近2.5%挑戰10天線高見30,453無以為繼，收市僅彈1.2%後，今早在港交所(00388.HK)、中移動(00941.HK)、騰訊(00700.HK)及美團(03690.HK)低開逾2%-5.5%拖累，低開662點或2.2%報29,412，跌幅隨即擴至927點，低見29,147守穩本月初低位，跌幅曾收窄，回升至29,579，現造29,356，回吐717點或2.4%，成交額1,310億元。
藍籌股普遍跌逾1%-3%，其中重磅股騰訊低見665元守穩50天線，現造670元，跌3.1%；藥明生物(02269.HK)低見95.9元創個半月低，現造96.3元，挫7.6%為最傷藍籌。
昨午公布去年僅盈轉蝕39.73億元勝預期的銀娛(00027.HK)績後大行目標價介乎61.5-88元，花旗及里昂最進取，匯豐及瑞銀最保守。該股由紀錄高位連吐三天，今早失守10天線(70.74元)，最低見68.05元，現造69.6元，續挫6%為表現第二差藍籌。金沙(01928.HK)低見35.8元，現造36.2元(剛為10天線)，跌逾4%。
港交所及美團曾失50天線(479.5元347.4元)，最低見468元及344元，現造479.2元及348.4元，下挫4.2%及5.9%，前者由紀錄高位五連跌。
蘋果股價四連跌，昨晚更挫逾3.5%，舜宇(02382.HK)跌破50天線(196元)，最低見190元，現造194.2元，挫5.1%。小米(01810.HK)跌4.8%曾報25.55元，創逾兩個半月低。阿里(09988.HK)及百威亞太(01876.HK)也挫逾4%分別低見230.8元及23.95元，股價均失守牛熊線(238元及24.2元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
